A. Evans

P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial

A. Marneros, M. Tohen, R. Belmaker, 2003, European Neuropsychopharmacology.

P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial

J. Calabrese, M. Tohen, C. Bowden, 2003, European Neuropsychopharmacology.

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania.

R. Emsley, M. Tohen, M. Hardy-Bayle, 2003, Archives of general psychiatry.

Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

Joseph R Calabrese, Mauricio Tohen, Liliana Dell'Osso, 2005, The American journal of psychiatry.

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

J. Calabrese, M. Tohen, P. Mitchell, 2003, Archives of general psychiatry.

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

D. Kupfer, J. Calabrese, M. Tohen, 2004, British Journal of Psychiatry.

Olanzapine combined with mood stabilizers in prevention of recurrence in bipolar disorder: An 18-month study

J. Calabrese, M. Tohen, R. Baker, 2002, European Neuropsychopharmacology.

Olanzapine cotherapy in prevention of recurrence in bipolar disorder

R. Baker, T. Suppes, R. Risser, 2002, European psychiatry.